Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jie Zha

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
International Journal of Biological Sciences|September 17, 2025
Therapeutic Activation of PPARα Inhibits Transformed Follicular Lymphoma Tumorigenesis via the FOXM1 Signaling PathwayDongmei Qin, Hui Zhou, Jie Zhou, et al.
Experimental Hematology & Oncology|December 19, 2024
Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemiaHongpeng Duan, Qian Lai, Yuelong Jiang, et al.
International Journal of Clinical and Experimental Pathology|November 16, 2023
Angiotensin-converting enzyme - human amniotic mesenchymal stem cells improve pulmonary vascular remodeling in rats with pulmonary hypertension by promoting angiogenesis and counteracting inflammationChangfang Wu, Hao Liu, Mingchuan Ba, et al.
Cell Death & Disease|March 24, 2026
Dual targeting of PI3Kδ and PPARα enhances antitumor activity via FoxO1 activation in follicular lymphomaWenqin Wang, Hui Zhou, Shuangxiong Tan, et al.
Pharmaceuticals (Basel, Switzerland)|November 10, 2022
Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem CellsYuelong Jiang, Long Liu, Yirong Jiang, et al.
Scientific Reports|November 11, 2024
Changes of T cell subsets across treatments associated with prognosis in newly diagnosed follicular lymphomaQiuhui Jiang, Feng Lin, Zhifeng Li, et al.
Frontiers in Immunology|May 30, 2024
A potential defensive role of TIM-3 on T lymphocytes in the inflammatory involvement of diabetic kidney diseaseXiao-Jun Chen, Runyan Tang, Jie Zha, et al.
World Journal of Pediatrics : WJP|January 20, 2017
Impact of relocation and environmental cleaning on reducing the incidence of healthcare-associated infection in NICUQiu-Fang Li, Hong Xu, Xiao-Ping Ni, et al.
International Immunopharmacology|March 6, 2024
Lactate acid promotes PD-1<sup>+</sup> Tregs accumulation in the bone marrow with high tumor burden of Acute myeloid leukemiaYining Zhang, Yueting Huang, Yan Hong, et al.
Current Medical Science|April 15, 2024
Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic LeukemiaZhen Lu, Qian Lai, Zhi-Feng Li, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Biological Sciences|September 17, 2025
Therapeutic Activation of PPARα Inhibits Transformed Follicular Lymphoma Tumorigenesis via the FOXM1 Signaling PathwayDongmei Qin, Hui Zhou, Jie Zhou, et al.
Experimental Hematology & Oncology|December 19, 2024
Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemiaHongpeng Duan, Qian Lai, Yuelong Jiang, et al.
International Journal of Clinical and Experimental Pathology|November 16, 2023
Angiotensin-converting enzyme - human amniotic mesenchymal stem cells improve pulmonary vascular remodeling in rats with pulmonary hypertension by promoting angiogenesis and counteracting inflammationChangfang Wu, Hao Liu, Mingchuan Ba, et al.
Cell Death & Disease|March 24, 2026
Dual targeting of PI3Kδ and PPARα enhances antitumor activity via FoxO1 activation in follicular lymphomaWenqin Wang, Hui Zhou, Shuangxiong Tan, et al.
Pharmaceuticals (Basel, Switzerland)|November 10, 2022
Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem CellsYuelong Jiang, Long Liu, Yirong Jiang, et al.
Scientific Reports|November 11, 2024
Changes of T cell subsets across treatments associated with prognosis in newly diagnosed follicular lymphomaQiuhui Jiang, Feng Lin, Zhifeng Li, et al.
Frontiers in Immunology|May 30, 2024
A potential defensive role of TIM-3 on T lymphocytes in the inflammatory involvement of diabetic kidney diseaseXiao-Jun Chen, Runyan Tang, Jie Zha, et al.
World Journal of Pediatrics : WJP|January 20, 2017
Impact of relocation and environmental cleaning on reducing the incidence of healthcare-associated infection in NICUQiu-Fang Li, Hong Xu, Xiao-Ping Ni, et al.
International Immunopharmacology|March 6, 2024
Lactate acid promotes PD-1<sup>+</sup> Tregs accumulation in the bone marrow with high tumor burden of Acute myeloid leukemiaYining Zhang, Yueting Huang, Yan Hong, et al.
Current Medical Science|April 15, 2024
Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic LeukemiaZhen Lu, Qian Lai, Zhi-Feng Li, et al.
Pageof 9